Scientists at ORNL have developed 3D-printed collimator techniques that can be used to custom design collimators that better filter out noise during different types of neutron scattering experiments
How do you get water to float in midair? With a WAND2, of course. But it’s hardly magic. In fact, it’s a scientific device used by scientists to study matter.
Currently, the biggest hurdle for electric vehicles, or EVs, is the development of advanced battery technology to extend driving range, safety and reliability.
Neutron experiments can take days to complete, requiring researchers to work long shifts to monitor progress and make necessary adjustments. But thanks to advances in artificial intelligence and machine learning, experiments can now be done remotely and in half the time.
Oak Ridge National Laboratory researchers are developing a first-of-its-kind artificial intelligence device for neutron scattering called Hyperspectral Computed Tomography, or HyperCT.
Oak Ridge National Laboratory researchers demonstrated that microchannel heat exchangers in heating, ventilation and air conditioning units can keep refrigerants evenly and continually distributed by inserting a device called a piezoelectric-driven
Oak Ridge National Laboratory researchers demonstrated that an electrochemical sensor paired with a transmitter not only detects propane leaks within seconds, but it can also send a signal to alert emergency services.
Oak Ridge National Laboratory researchers developed and demonstrated algorithm-based controls for a hybrid electric bus that yielded up to 30% energy savings compared with existing controls.
Oak Ridge National Laboratory researchers designed and field-tested an algorithm that could help homeowners maintain comfortable temperatures year-round while minimizing utility costs.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.